<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_UX94phj">The influence of physical activity on risk of cardiovascular disease in people who are obese but metabolically healthy</title>
				<funder ref="#_HYVWxkU">
					<orgName type="full">Ministry of Education</orgName>
					<orgName type="abbreviated">MOE</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100009950</idno>
				</funder>
				<funder ref="#_BJFzMaN">
					<orgName type="full">Korean Diabetes Association, Basic Science Research Program</orgName>
				</funder>
				<funder>
					<orgName type="full">National Research Institute of Health, Centers for Disease Control and Prevention, Ministry for Health and Welfare, Republic of Korea</orgName>
				</funder>
				<funder>
					<orgName type="full">National Research Foundation of Korea</orgName>
					<orgName type="abbreviated">NRF</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100003725</idno>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">Â© 2017 Moon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
				</availability>
				<date type="published" when="2017-09-26">September 26, 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Shinje</forename><surname>Moon</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Division of Endocrinology and Metabolism , Hallym University College of Medicine , Chuncheon , South Korea ,</note>
								<orgName type="department">Division of Endocrinology and Metabolism</orgName>
								<orgName type="institution">Hallym University College of Medicine</orgName>
								<address>
									<settlement>Chuncheon</settlement>
									<country key="KR">South Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chang-Myung</forename><surname>Oh</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Division of Endocrinology and Metabolism , CHA Bundang Medical Center , School of Medicine CHA University , Pangyo , Seongnam , South Korea</note>
								<orgName type="department" key="dep1">Division of Endocrinology and Metabolism</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution" key="instit1">CHA Bundang Medical Center</orgName>
								<orgName type="institution" key="instit2">CHA University</orgName>
								<address>
									<settlement>Pangyo Seongnam</settlement>
									<country key="KR">South Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Moon-Ki</forename><surname>Choi</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Division of Endocrinology and Metabolism , Hallym University College of Medicine , Chuncheon , South Korea ,</note>
								<orgName type="department">Division of Endocrinology and Metabolism</orgName>
								<orgName type="institution">Hallym University College of Medicine</orgName>
								<address>
									<settlement>Chuncheon</settlement>
									<country key="KR">South Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yoo-Kyung</forename><surname>Park</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Division of Endocrinology and Metabolism , Hallym University College of Medicine , Chuncheon , South Korea ,</note>
								<orgName type="department">Division of Endocrinology and Metabolism</orgName>
								<orgName type="institution">Hallym University College of Medicine</orgName>
								<address>
									<settlement>Chuncheon</settlement>
									<country key="KR">South Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sukyung</forename><surname>Chun</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Division of Endocrinology and Metabolism , CHA Bundang Medical Center , School of Medicine CHA University , Pangyo , Seongnam , South Korea</note>
								<orgName type="department" key="dep1">Division of Endocrinology and Metabolism</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution" key="instit1">CHA Bundang Medical Center</orgName>
								<orgName type="institution" key="instit2">CHA University</orgName>
								<address>
									<settlement>Pangyo Seongnam</settlement>
									<country key="KR">South Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Minkyung</forename><surname>Choi</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Division of Endocrinology and Metabolism , CHA Bundang Medical Center , School of Medicine CHA University , Pangyo , Seongnam , South Korea</note>
								<orgName type="department" key="dep1">Division of Endocrinology and Metabolism</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution" key="instit1">CHA Bundang Medical Center</orgName>
								<orgName type="institution" key="instit2">CHA University</orgName>
								<address>
									<settlement>Pangyo Seongnam</settlement>
									<country key="KR">South Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jae</forename><forename type="middle">Myung</forename><surname>Yu</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Division of Endocrinology and Metabolism , Hallym University College of Medicine , Chuncheon , South Korea ,</note>
								<orgName type="department">Division of Endocrinology and Metabolism</orgName>
								<orgName type="institution">Hallym University College of Medicine</orgName>
								<address>
									<settlement>Chuncheon</settlement>
									<country key="KR">South Korea</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>Hyung</roleName><forename type="first">Joon</forename><surname>Yoo</surname></persName>
							<email>hjoonyoo@gmail.com</email>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Division of Endocrinology and Metabolism , Hallym University College of Medicine , Chuncheon , South Korea ,</note>
								<orgName type="department">Division of Endocrinology and Metabolism</orgName>
								<orgName type="institution">Hallym University College of Medicine</orgName>
								<address>
									<settlement>Chuncheon</settlement>
									<country key="KR">South Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">Universitat de les Illes Balears , SPAIN</note>
								<orgName type="institution">Universitat de les Illes Balears</orgName>
								<address>
									<country key="ES">SPAIN</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_uAmMA68">The influence of physical activity on risk of cardiovascular disease in people who are obese but metabolically healthy</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-09-26">September 26, 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">343363B983FEC649AD43A22388B150C1</idno>
					<idno type="DOI">10.1371/journal.pone.0185127</idno>
					<note type="submission">Received: May 1, 2017 Accepted: September 5, 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T10:40+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_SE2Bmam"><p xml:id="_wGurNZd"><s xml:id="_bg3U2vH">The metabolic outcomes of metabolically healthy obesity (MHO) remain controversial.</s><s xml:id="_RZ2vgyK">The aim of the present study was to determine the effect of physical activity on the cardiovascular disease (CVD) outcomes of MHO.</s><s xml:id="_Ck8Bp2D">The study included participants who were followed for 10 years and recruited from the Korean Genome and Epidemiology Study (KoGES), a population-based cohort study.</s><s xml:id="_hPxsqVE">Participants with previously recorded CVDs or cancer, or who had received steroids or anticoagulants at baseline were excluded.</s><s xml:id="_tRekbJx">A total of 8144 participants (3,942 men and 4,202 women) fulfilled inclusion criteria.</s><s xml:id="_3sTrzv6">In a multivariate Cox regression model adjusted for age and sex, MHO participants were not at elevated risk of CVD compared with their metabolically healthy non-obese (MHNO) counterparts (HR, 1.28; 95% CI, 0.96-1.71),</s><s xml:id="_UjT6WCK">although both the non-obese (HR, 1.50; 95% CI, 1.19-1.90)</s><s xml:id="_WTS2DDV">and obese (HR, 1.85; 95% CI, 1.48-2.30)</s><s xml:id="_5V9hSeS">participants with metabolic abnormalities were at elevated risk.</s><s xml:id="_7KGpBZ4">However, in the subgroup analysis by physical activity, physically inactive MHO participants had a significantly higher HR for CVD events compared to active MHNO participants (HR, 1.54; 95% CI, 1.03-2.30),</s><s xml:id="_mbY3nXY">while active MHO participants were not at elevated risk (HR, 1.15; 95% CI, 0.70-1.89).</s><s xml:id="_CFJSECr">Physically inactive MHO participants had significantly increased risk of CVD compared to physically active MHNO participants whereas physically active MHO participants did not.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2dDQm7d">Introduction</head><p xml:id="_MJ7Nsz5"><s xml:id="_7yPQC6d">The incidence of obesity is increasing and the worldwide prevalence of obesity more than doubled between 1980 and 2012 <ref type="bibr" target="#b1">[1]</ref>.</s><s xml:id="_vMy8We5">In Korea, the prevalence of obesity has increased over the past 10 years (20.6% to 24.6% in men, 16.2% to 17.3% in women from 2006 to 2015) <ref type="bibr" target="#b2">[2]</ref>.</s><s xml:id="_bc9seWj">These changes are particularly important given the known association between obesity with cardiovascular disease (CVD), diabetes, and death <ref type="bibr" target="#b3">[3]</ref>.</s></p><p xml:id="_r5apKe4"><s xml:id="_vrFV965">Intriguingly, obesity is not synonymous with metabolic disease, as people who are overweight or obese do not always have no metabolic dysfunction, especially cardio-metabolic dysfunction.</s><s xml:id="_cmhdXpr">These populations have been called the metabolically healthy obesity (MHO) phenotype.</s><s xml:id="_f3bchn5">The underlying mechanisms which cause MHO phenotype among obese people are multiple and complex.</s><s xml:id="_CGRJa6Z">This phenotype is the result of complex interaction between genetic, environmental, and behavioral factors <ref type="bibr" target="#b4">[4]</ref>.</s><s xml:id="_wrhGGhy">The absence of genetic traits associated with fat distribution, reduced visceral fat mass and ectopic fat accumulation in liver, muscle, and pancreatic beta cells, and low systemic inflammation all contribute to metabolically healthy obesity <ref type="bibr" target="#b4">[4]</ref>.</s></p><p xml:id="_vczHChh"><s xml:id="_UbtUBms">The diagnostic criteria for MHO is controversial, and therefore the prevalence of MHO is difficult to quantify and varies according to the definition used <ref type="bibr" target="#b5">[5]</ref>.</s><s xml:id="_mARSckk">The prevalence of MHO has been reported to be 10-25% worldwide <ref type="bibr" target="#b6">[6,</ref><ref type="bibr" target="#b7">7]</ref>, while the estimated prevalence among middle-age men in Korea is 24.2-28.5% <ref type="bibr" target="#b8">[8]</ref>.</s><s xml:id="_FgVEqNm">A recent review article reported that the prevalence of MHO showed a large variation from 6% to 75% <ref type="bibr" target="#b9">[9]</ref>.</s></p><p xml:id="_bgNWvDV"><s xml:id="_jxKuX4G">Although, by definition, people with MHO are metabolically 'healthy', the metabolic outcomes of MHO remain unclear.</s><s xml:id="_nugMB7c">Regarding cardiovascular outcomes in this group of patients, Hamer et al. <ref type="bibr" target="#b10">[10]</ref> observed 22,203 subjects without CVD for more than 7 years.</s><s xml:id="_KhGjS2f">This observational study revealed that MHO did not increase the risk for all-cause or cardiovascular mortality.</s><s xml:id="_RPxPnYD">Furthermore, MHO has little association with heart failure <ref type="bibr" target="#b11">[11]</ref> and with coronary atherosclerosis <ref type="bibr">[12]</ref>.</s><s xml:id="_x99DK2r">On the contrary, several large observational studies reported that MHO is a significant risk factor for CVD.</s><s xml:id="_Bn5umvu">Ogorodnikova et al. <ref type="bibr" target="#b12">[13]</ref> conducted a 12-year observational study and demonstrated patients with MHO had high risk of CVD compared to metabolically healthy normal weight individuals.</s><s xml:id="_CYfDGXC">Kramer et al. <ref type="bibr" target="#b13">[14]</ref> reviewed 8 studies about all-cause mortality and cardiovascular events and concluded that obesity is an independent risk factor for CVD in patients with and without metabolic disorders.</s></p><p xml:id="_6WKfnrc"><s xml:id="_6cp8RsH">These discrepancies suggest that MHO alone is not sufficient to predict metabolic outcome and patients with MHO likely represent a heterogeneous group.</s><s xml:id="_WZUve9x">Therefore, it remains important to identify the key factors that determine healthy outcomes in MHO and to re-define metabolically healthy obesity.</s></p><p xml:id="_mQebzbs"><s xml:id="_uTH6qPg">In this study, we focused on physical activity (PA) as a key factor, since it is well known to influence obesity, and because physical inactivity contributes to the development of metabolic disorders such as heart disease, hypertension, and type 2 diabetes mellitus (T2DM) <ref type="bibr" target="#b14">[15]</ref>.</s><s xml:id="_ZRjMDAK">The World Health Organization (WHO) recommends that adults should perform at least 150 minutes of moderate-intensity aerobic physical activity (PA) or 75 minutes of vigorous-intensity aerobic PA throughout the week <ref type="bibr" target="#b15">[16]</ref>.</s><s xml:id="_aN8dU6S">The U.S. Department of Health and Human Services also recommends at least 150 minutes of PA for major health benefits <ref type="bibr" target="#b16">[17]</ref>.</s></p><p xml:id="_CCtgtP5"><s xml:id="_pQemP9E">Many studies have reported that the amount of PA has inverse dose-response associations with coronary heart disease and CVD <ref type="bibr" target="#b17">[18]</ref> and regular exercise improves insulin sensitivity and reduces glycosylated hemoglobin (HbA1c) levels in T2DM patients <ref type="bibr" target="#b18">[19]</ref>.</s></p><p xml:id="_5BdT3ve"><s xml:id="_b5KXc6J">In the present study, patients with MHO were divided into four groups based on their level of PA, and we evaluated the risk of CVD in a Korean population-based cohort.</s><s xml:id="_3xbsgw6">The aim of the present study was to determine the effect of PA on CVD outcomes of MHO and to re-define the concept of "real" metabolic health.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_db8WxQF">Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_J3XcaUk">Study population</head><p xml:id="_Wk2eBV5"><s xml:id="_UpmtrtV">This was a prospective cohort study in which data were collected from two population-based cohorts from Ansan and Ansung, Korea, and was as part of the Korean Genome and Epidemiology Study (KoGES), a Korean government-funded epidemiological survey to investigate trends in chronic noncommunicable diseases and associated risk factors.</s><s xml:id="_PYYr3Zs">A total of 10,038 participants were examined at baseline in 2001-2002 and the biennial follow-up examination is ongoing.</s><s xml:id="_7ZHWUxm">The design of the cohort study and the demographics of participants have been described elsewhere <ref type="bibr" target="#b19">[20]</ref>.</s></p><p xml:id="_TGXzagn"><s xml:id="_TQkSYCY">The 10-year follow-up data are included in the present study.</s><s xml:id="_pSuaqHY">The following participants were excluded from the present study: those with incomplete data (demographic, anthropometric, or laboratory), those with a clinical history of CVD or cancer at baseline, and those who had received steroids or anticoagulants.</s><s xml:id="_ZeEUyne">The total number of eligible participants was 8,144.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_B3WBCaE">Measurement</head><p xml:id="_4Zh3jwX"><s xml:id="_ZKG9xd5">Height and body weight were measured to the nearest 0.1cm or 0.2kg, respectively.</s><s xml:id="_Ef9ANMa">Blood pressure (BP) was measured in the sitting position after at least 5 minutes of rest.</s><s xml:id="_8JZgqrz">Blood samples were obtained after an overnight fast of at least 8 h, and biochemical assays including plasma glucose, total cholesterol (TC), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) were measured using the ADVIA 1650 chemistry analyzer (Bayer HealthCare Ltd., Tarrytown, NY, USA).</s><s xml:id="_2Jr7ZC5">Hemoglobin A1c (HbA1c) level was measured using high-performance liquid chromatography (Variant II; BioRad Laboratories, Hercules, CA, USA)</s></p><p xml:id="_HymPpEK"><s xml:id="_h6d8HKg">The questionnaire included questions on sociodemographic information, lifestyle, personal and familial medical history, smoking status and alcohol consumption.</s><s xml:id="_tkK3M2q">The participants were classified as non-, ex-, and current drinkers and never-, ex-, and current smokers based on their response to lifetime alcohol consumption and smoking status on the questionnaire.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_JSgDA8r">Definition</head><p xml:id="_GneaQVV"><s xml:id="_e6mF8Px">There is no consensus regarding the diagnosis of metabolically healthy obesity.</s><s xml:id="_ejCNAUR">In the present study, non-obese participants were defined as those with a body mass index (BMI) of 18-25 kg/m 2 and obesity as a BMI of !25 kg/m 2 according to Asia-Pacific BMI criteria, which are defined by the WHO Western Pacific Region <ref type="bibr" target="#b20">[21]</ref>.</s><s xml:id="_QAWDZ46">Metabolic risk was based on an adaptation of the Adult Treatment Panel-III (ATP-III) definition of metabolic syndrome, and defined as two or more metabolic risk factors, including hypertension (a systolic blood pressure (BP) at least 130 mmHg and/or a diastolic BP at least 85 mmHg, or on antihypertensive treatment), impaired fasting glucose (fasting plasma glucose at least 100 mg/dL), triglycerides (TG) at least 150 mg/dL, and adverse high density lipoprotein (HDL) cholesterol (1.03 mmol/L in men and 1.30 mmol/L in women).</s><s xml:id="_UedNsKP">The waist circumference (WC) criterion was not used because of its collinearity with BMI.</s><s xml:id="_5jcJdk2">According to these criteria, participants were categorized into one of four groups consisting of metabolically healthy non-obese (MHNO); metabolically healthy obese (MHO); metabolically unhealthy non-obese (MUNO); and metabolically unhealthy obese (MUO).</s><s xml:id="_8BRz44r">All participants completed a structured questionnaire that included healthrelated questions concerning PA.</s><s xml:id="_2fuRtHZ">The PA categories included a physically active group (at least 30 minutes per day of PA) and an insufficient group (fewer than 30 minutes per day of PA).</s><s xml:id="_ahjtCVE">Because there was no data about average minutes of PA per week in the baseline data, we were unable to use the WHO recommendation <ref type="bibr" target="#b15">[16]</ref>.</s><s xml:id="_wzGNxxy">However, the intensity and average minutes per week of PA were investigated at the first follow-up survey and we conducted subgroup analysis of participants with the first follow-up data using the WHO definition which recommends at least 150 minutes of moderate-intensity aerobic PA or 75 minutes of vigorousintensity aerobic PA throughout the week.</s><s xml:id="_4xhx5f3">CVD events were investigated with a structured questionnaire and defined as any of the following: myocardial infarction, coronary heart disease, congestive heart failure, cerebrovascular disease, or peripheral arterial disease.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_f6SvxMp">Statistical analysis</head><p xml:id="_c2Z2khT"><s xml:id="_jmVak2q">All data are presented as the mean and standard deviation, or prevalence (%) and 95% confidence interval (CI).</s><s xml:id="_qmwgp9U">The independent sample t-test or one-way analysis of variance (ANOVA) was used to compare continuous variables and Pearson's chi-square test was used to compare proportions according to metabolic health and obesity status.</s><s xml:id="_6w2AprE">Cox proportional hazards regression models, unadjusted and adjusted, were constructed to evaluate the hazards ratio (HR) and 95% CI for CVD events in groups classified according to metabolic health and obesity status.</s><s xml:id="_x7wXfgB">Follow-up time was calculated as time from first anthropometric and clinical measures to date of CVD events or time from first anthropometric and clinical measurement to end of follow-up (December 31, 2012).</s><s xml:id="_ZKqMef2">Analyses were performed using SPSS version 21.0 software (IBM, Armonk, NY, USA).</s><s xml:id="_FQVmDm3">The significance levels were set at 0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QhWFPDm">Ethics statement</head><p xml:id="_MaVZYvE"><s xml:id="_VXDFzaK">The institutional review board of Bundang CHA Hospital (South Korea) approved the study protocol (IRB No. CHAMC 2016-08-017), and all participants volunteered and provided written informed consent prior to their enrollment.</s><s xml:id="_vN6EdFq">All participants' records were anonymized before being accessed by the authors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_3ZKhmMn">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uzcEAms">Baseline characteristics</head><p xml:id="_s6ZHUAC"><s xml:id="_6UkJeqq">Data from 8,144 participants (3,942 men and 4,202 women) were assessed.</s><s xml:id="_BF2gVAt">The anthropometric, clinical, and biochemical characteristics of the participants classified by obesity and metabolic health status are summarized in Table <ref type="table">1</ref>.</s></p><p xml:id="_NZW8fbv"><s xml:id="_a7hsDXr">Among the included participants, 15.5% exhibited the MHO phenotype.</s><s xml:id="_mK7jyVm">Compared to MHNO participants, those with the MHO phenotype tended to be female and have a high BMI (both p&lt;0.01).</s><s xml:id="_MDfGbNc">However, other characteristics such as mean age, alcohol drinking, smoking status, and metabolic parameters did not differ significantly between the two groups.</s><s xml:id="_VeVNgB9">Participants with MUNO and MUO phenotype were more likely to be older and to have higher BP, TG, and HbA1c levels, lower levels of HDL-C, and a higher prevalence of prehypertension and prediabetes than those with MHNO and MHO phenotypes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_bC4xz7D">Association between CVD events and metabolically healthy-obesity phenotype</head><p xml:id="_Km8fXhw"><s xml:id="_nd8ukHK">A total of 568 CVD events were reported during the 10 years.</s><s xml:id="_5Q5s4GY">Kaplan-Meier survival curves revealed a significantly higher rate of CVD events in participants with the MUNO and MUO phenotypes than in those with the MHNO phenotype (MUNO vs. MHNO, p &lt; 0.001; MUO vs. MHNO, p&lt; 0.001).</s><s xml:id="_kwftgu5">However, there was no significant difference between participants with the MHNO and MHO phenotype (p = 0.272; <ref type="bibr">Fig 1)</ref>.</s></p><p xml:id="_WgKhQzg"><s xml:id="_SqKdXdC">In a multivariate Cox regression model adjusted for age and gender, MHO participants were not at elevated risk of CVD compared with their MHNO counterparts (HR, 1.28; 95% CI, 0.96-1.71),</s><s xml:id="_S9B5HeV">although both the non-obese (HR, 1.50; 95% CI, 1.19-1.90)</s><s xml:id="_VtezVMe">and obese (HR, 1.85; 95% CI, 1.48-2.30)</s><s xml:id="_KZbV5Ag">participants with metabolic abnormalities were at elevated risk (Table <ref type="table">2</ref>).</s><s xml:id="_djFDuWF">Similar results were seen after adjustment for age, gender, and other covariates such as alcohol drinking, smoking, PA, and medications.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2hU9PqT">Effects of physical activity on CVD events by obesity and metabolic health status</head><p xml:id="_2gSmUB8"><s xml:id="_Y5GNkcF">We further performed a subgroup analysis by PA status.</s><s xml:id="_aJkHJe3">Participants with the MUNO and MUO phenotype were more likely to be physically inactive than those with the MHNO and MHO phenotype (Table <ref type="table">1</ref>).</s><s xml:id="_7wdfJT2">The adjusted HRs of CVD events by PA, obesity, and metabolic health status are shown in Table <ref type="table">3</ref>.</s></p><p xml:id="_XxKFnCA"><s xml:id="_8xq3hu3">In a multivariate Cox regression model adjusted for age and gender, the HR for CVD events slightly increased from 1.89 (95% CI, 1.30-2.74) in active participants with MUO reaching 2.05 (95% CI, 1.48-2.85) in inactive counterparts with MUO compared to physically active MHNO participants.</s><s xml:id="_pEs35HG">A similar increase of HR was found in those with MUNO as well (HR, 1.60; 95% CI, 1.08-2.36 in active participants; HR, 1.64; 95% CI, 1.16-2.32 in inactive participants).</s><s xml:id="_xpxmhD7">Compared to active MHNO participants, physically inactive MHO participants had a significantly higher HR for CVD events (HR, 1.54; 95% CI, 1.03-2.30),</s><s xml:id="_AFWhMxc">while active participants were not at elevated risk of CVD (HR, 1.15; 95% CI, 0.70-1.89).</s><s xml:id="_rVpSuce">The subgroup analysis with the first follow-up data for PA showed comparable results (S1 Table ).</s><s xml:id="_fVjstCq">In addition, we</s></p><p xml:id="_xaQ6qe9"><s xml:id="_73bhbtt">Table 1.</s><s xml:id="_JKxgXDh">Characteristics of subjects according to obesity and metabolic health status.</s><s xml:id="_sxyKwh8">MHNO (N = 2929) MHO (N = 1262) MUNO (N = 1743) MUO (N = 2210) P-value Men, N 1501 (51.2%) 560 (44.4%) 875 (50.2%) 1006 (45.5%) &lt;0.001 Age, years 48 (43-58) 48 (43-56) 55 (46-63) 52 (45-60) &lt;0.001 Alcohol, N &lt;0.001</s><s xml:id="_PgWU5Ke">Never drinker 1265 (43.2%) 528 (41.8%) 819 (47.0%) 1102 (49.9%)</s><s xml:id="_cJKhKzP">Ex-drinker 167 (5.7%) 74 (5.9%) 116 (6.7%) 147 (6.7%)</s><s xml:id="_gK4X4Sf">Current drinker 1497 (51.1%) 660 (52.3%) 808 (46.4%) 961 (43.5%)</s><s xml:id="_qKtKXE4">Smoking, N &lt;0.001</s><s xml:id="_9cnbnWu">Never smoker 1651 (56.4%) 806 (63.9%) 979 (56.2%) 1342 (60.7%)</s><s xml:id="_3nqCEA2">Ex-smoker 434 (14.8%) 201 (15.9%) 283 (16.2%) 354 (16.0%)</s><s xml:id="_Mam4fQM">Current smoker 844 (28.8%) 255 (20.2%) 481 (27.6%) 514 (23.3%)</s><s xml:id="_EB8G5dW">Physical activity*, N 1139 (38.9%) 504 (39.9%) 616 (35.3%) 760 (34.4%) 0.001 BMI, Kg/m 2 22.5 (21.0-23.7)</s><s xml:id="_Yqu8fhW">26.6 (25.7-28.0)</s><s xml:id="_4fkHARm">23.3 (22.0-24.2) 27.0 (26.0-28.7)</s><s xml:id="_Vu5Jjbp">&lt;0.001 Systolic BP, mmHg 112 (104-121) 114 (106-122) 127 (114-139) 128 (117-140) &lt;0.001 Diastolic BP, mmHg 75 (69-81) 78 (71-83) 84 (75-90) 86 (78-92) &lt;0.001</s><s xml:id="_hrspeRv">Total cholesterol, mg/dL 182 (161-205) 193 (169-217) 188 (165-213) 197 (175-222) &lt;0.001 HDL-C, mg/dL 48.0 (42.0-55.0)</s><s xml:id="_Wq7Zr7Z">46.0 (41.0-52.0)</s><s xml:id="_ZvkHR9Q">40.0 (35.0-45.5)</s><s xml:id="_4Fch5Fv">39.0 (35.0-44.0)</s><s xml:id="_QYAT6v2">&lt;0.001 Triglycerides, mg/dL 104 (83-128) 114 (92-138) 180 (147-235) 189 (153-256) &lt;0.001 HbA1c, % 5.5 (5.3-5.7)</s><s xml:id="_ZBJqcDK">5.5 (5.3-5.8)</s><s xml:id="_mtT4aFJ">5.7 (5.4-6.0)</s><s xml:id="_uw2Z25A">5.8 (5.5-6.2) &lt;0.001 Metabolic state, N Hyperglycemia 93 (3.2%) 47 (3.7%) 479 (27.5%) 687 (31.1%) &lt;0.001</s><s xml:id="_zxFkHZp">Low HDL-C 876 (29.9%) 447 (35.4%) 1313 (75.3%) 1783 (80.7%) &lt;0.001 High TG 247 (8.4%) 163 (12.9%) 1290 (74.0%) 1700 (76.9%) &lt;0.001 CVD events â  , N 135 (4.6%) 70 (5.5%)</s><s xml:id="_sCbJNvb">155 (8.9%) 208 (9.4%) &lt;0.001 Follow up time, years 8.3 (8.2-8.4)</s><s xml:id="_tn6H42x">8.5 (8.3-8.6)</s><s xml:id="_XYYaVJ8">8.2 (8.0-8.3)</s><s xml:id="_mCUxAK9">8.1 (8.0-8.3)</s><s xml:id="_BXaTX8A">0.002 Abbreviations: MHNO, metabolically healthy nonobese; MHO, metabolically healthy obese; MUNO, metabolically unhealthy nonobese; and MUO, metabolically unhealthy obese; N; number, BP, blood pressure; HDL-C, high dense lipoprotein cholesterol, CVD, cardiovascular diseases.</s><s xml:id="_nUk5k4p">* Participants who engaged in physical activity for at least 30 minutes per day â  Participants who had either myocardial infarction, coronary heart disease, congestive heart failure, cerebrovascular disease or peripheral arterial disease Data were presented as the means (95% CI) or numbers (%) <ref type="url" target="https://doi.org/10.1371/journal.pone.0185127.t001">https://doi.org/10.1371/journal.pone.0185127.t001</ref></s></p><p xml:id="_YmVk74B"><s xml:id="_CTxfFFP">conducted further analysis with MHNO and MHO participants by presence of metabolic abnormality and found that MHO with one metabolic abnormality and inactive PA increased the risk of CVD event (HR; 1.786; 95% CI, 1.047-2.987)</s><s xml:id="_vKycnRC">whereas those with no metabolic abnormality or active PA did not (Table <ref type="table">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SUHksu3">Discussion</head><p xml:id="_Vqn4eth"><s xml:id="_R7Pw3v2">In this study, we performed a long-term follow-up study of Korean patients and analyzed the risk for CVD in patients with MHO phenotype.</s><s xml:id="_Ddtfpqc">The MUO and MUNO groups had significantly higher risk for CVD than the MHNO group.</s><s xml:id="_T4bg6hu">Although the present study failed to find significant results between the MHO and MHNO groups, the subgroup analysis by PA status showed that the MHO group with insufficient PA had worse prognosis than the MHNO group Table 2. Hazard ratios for CVD events according to obesity and metabolic health status.</s><s xml:id="_PZAhWB9">Model1 Model2 HR (95%CI) P HR (95%CI) P MHNO 1 (Reference) 1 (Reference) MHO 1.280 (0.957-1.710) 0.096 1.288 (0.963-1.723) 0.088 MUNO 1.503 (1.190-1.899)</s><s xml:id="_5rTpPFs">0.001 1.358 (1.071-1.724)</s><s xml:id="_XrNnzGj">0.012 MUO 1.847 (1.484-2.299)</s><s xml:id="_P6axAay">&lt;0.001 1.596 (1.268-2.007)</s><s xml:id="_PBVrxVA">&lt;0.001 Abbreviations: MHNO, metabolically healthy nonobese; MHO, metabolically healthy obese; MUNO, metabolically unhealthy nonobese; and MUO, metabolically unhealthy obese; HR, hazard ratios; CI, confidential interval.</s><s xml:id="_wCvZNMs">Model 1 was adjusted for age and gender.</s><s xml:id="_XVfWwTh">Model 2 was adjusted for the variables in Model 1, plus alcohol drinking, smoking, physical activity and medication of hypertension, diabetes mellitus and dyslipidemia.</s><s xml:id="_tCf8mx2"><ref type="url" target="https://doi.org/10.1371/journal.pone.0185127.t002">https://doi.org/10.1371/journal.pone.0185127.t002</ref></s></p><p xml:id="_MKN3HvX"><s xml:id="_TBMbede">with sufficient PA.</s><s xml:id="_UNSXVBf">Interestingly, despite being obese, the prognosis of physically active individuals with MHO did not differ significantly from that of MHNO individuals.</s><s xml:id="_TXZTbPG">These results show that metabolically healthy obese populations are not homogenous.</s><s xml:id="_2yqQYps">This heterogeneity of 'obesity' is due to a limitation in the classification of obesity by BMI.</s><s xml:id="_NpmAtsG">First, obesity is defined as excess body fat mass, but BMI does not accurately reflect body fat mass <ref type="bibr" target="#b21">[22]</ref>, since bodyweight cannot distinguish between excess fat and excess muscle or bone mass.</s><s xml:id="_HKYduxa">Second, extra fat is not always bad.</s><s xml:id="_taTAvEU">Adipose tissue is a complex organ composed of white, beige, and brown fat.</s><s xml:id="_YayKQxQ">The beige/brown fat has many beneficial effects on metabolism <ref type="bibr" target="#b22">[23]</ref>.</s><s xml:id="_eRz9YtZ">Furthermore, the metabolic effects of fat differ according to its location.</s><s xml:id="_EwPEydt">For example, excess visceral fat mass has deleterious effects on metabolism and is an independent risk factor of metabolic syndrome, type 2 diabetes, CVD and cancer <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b24">25]</ref>, whereas subcutaneous fat has beneficial effects on metabolism <ref type="bibr" target="#b25">[26]</ref>.</s><s xml:id="_E8A3tFs">In one animal study, subcutaneous fat transplantation improved metabolic dysfunction in an obese mouse model <ref type="bibr" target="#b26">[27]</ref>.</s></p><p xml:id="_37xS3vM"><s xml:id="_tQxNu3z">In order to overcome this limitation of obesity classification according to BMI, many studies tried to evaluate obesity using other body index parameters such as waist circumference, waist hip ratio or waist height ratio <ref type="bibr" target="#b27">[28,</ref><ref type="bibr" target="#b28">29]</ref>, and reported that these other indexes explained</s></p><p xml:id="_7KVVpJ5"><s xml:id="_8aRQexG">Table 3. Hazard ratios for CVD events according to obesity, metabolic health status and physical activity.</s><s xml:id="_PGDMaAG">Model1 Model2 HR (95% CI) P HR (95% CI) P MHNO with active PA 1 (Reference) 1 (Reference) MHNO with inactive PA 1.129 (0.794-1.607) 0.498 1.112 (0.781-1.582) 0.557 MHO with active PA 1.147 (0.697-1.886) 0.590 1.147 (0.697-1.888) 0.590 MHO with inactive PA 1.536 (1.026-2.298)</s><s xml:id="_kejygVh">0.037 1.524 (1.018-2.281)</s><s xml:id="_RjNCP9P">0.041 MUNO with active PA 1.598 (1.081-2.361)</s><s xml:id="_vrqxSDF">0.019 1.438 (0.970-2.133) 0.071 MUNO with inactive PA 1.640 (1.160-2.320)</s><s xml:id="_kvk6D4e">0.005 1.467 (1.034-2.081)</s><s xml:id="_J6ndJsT">0.032 MUO with active PA 1.890 (1.304-2.741)</s><s xml:id="_R9VrCEZ">0.001 1.608 (1.101-2.349)</s><s xml:id="_FbQZxhH">0.014 MUO with inactive PA 2.051 (1.475-2.853)</s><s xml:id="_35FkWwJ">&lt;0.001 1.767 (1.262-2.474)</s><s xml:id="_566RybC">0.001 Abbreviations: MHNO, metabolically healthy nonobese; MHO, metabolically healthy obese; MUNO, metabolically unhealthy nonobese; and MUO, metabolically unhealthy obese; PA, physical activity; HR, hazard ratios; CI, confidential interval.</s><s xml:id="_gDCxD67">Model 1 was adjusted for age and gender.</s><s xml:id="_PYdTt69">Model 2 was adjusted for the variables in Model 1, plus drinking, smoking, physical activity and medication of hypertension, diabetes mellitus and dyslipidemia.</s><s xml:id="_dGFYeby"><ref type="url" target="https://doi.org/10.1371/journal.pone.0185127.t003">https://doi.org/10.1371/journal.pone.0185127.t003</ref></s><s xml:id="_AaEcbWe">Table 4. Age and sex adjusted hazard ratios for CVD events according to obesity, metabolic health status and physical activity based on strict definition.</s><s xml:id="_T2T2nQf">HR (95% CI) P MHNO with active PA (no metabolic abnormality) 1 (Reference) MHNO with inactive PA (no metabolic abnormality) 1,115 (0.653-1.906) 0.690 MHO with active PA (no metabolic abnormality) 1.256 (0.536-2.945) 0.599 MHO with inactive PA (no metabolic abnormality) 0.950 (0.424-2.127) 0.900 MHO with active PA (one metabolic abnormality) 1.111 (0.584-2.113) 0.748 MHO with inactive PA (one metabolic abnormality) 1.768 (1.047-2.987)</s><s xml:id="_NXnFgRg">0.033 Abbreviations: MHNO, metabolically healthy nonobese; MHO, metabolically healthy obese; MUNO, metabolically unhealthy nonobese; and MUO, metabolically unhealthy obese; PA, physical activity; HR, hazard ratios; CI, confidential interval.</s><s xml:id="_UZsUFBy"><ref type="url" target="https://doi.org/10.1371/journal.pone.0185127.t004">https://doi.org/10.1371/journal.pone.0185127.t004</ref></s></p><p xml:id="_gaSnDJA"><s xml:id="_FSp235u">obesity related metabolic disorders than BMI.</s><s xml:id="_rX69PaN">However, these indexes are still an indirect reflection of excess fat mass, and therefore additional clinical data accumulation is required to replace BMI.</s><s xml:id="_GWduuTZ">To measure regional body fat composition accurately, we can measure body composition or fat mass using computed tomography (CT), magnetic resonance imaging, DXA and PET-CT <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b30">31]</ref>.</s><s xml:id="_FDzRVFs">Unfortunately, these methods are expensive, and have limited availability and accessibility for long-term follow up in a large-scale cohort study.</s><s xml:id="_SueSDrT">Therefore, the degree of PA is an easily measured and inexpensive alternative to the methods described above which is useful in predicting the CVD risk of obesity and a suitable alternative to overcome the limitation of BMI.</s><s xml:id="_StQUsVU">In our data, the degree of PA acts an independent prognostic factor on the CVD outcome even in the same metabolic comorbidity.</s><s xml:id="_edHt7af">In fact, PA has been reported as a protective factor against the development of CVD in many clinical studies <ref type="bibr" target="#b17">[18]</ref>.</s><s xml:id="_B8PJhun">Jian Li et al. <ref type="bibr" target="#b31">[32]</ref> reported that PA reduced the overall risk of CVD among men and women by 20-30% and 10-20% percent, respectively.</s><s xml:id="_9TAzNSt">PA is an independent regulator of body fat percent and body composition <ref type="bibr" target="#b32">[33]</ref>, and is associated with the activity of brown adipose tissue <ref type="bibr" target="#b33">[34]</ref>.</s></p><p xml:id="_eHEzcbp"><s xml:id="_mJskjGt">In our study cohort, physically active individuals comprised 39.9% of the MHO group (Table <ref type="table">1</ref>).</s><s xml:id="_KSy8mhc">More than half of the participants in the MHO group were physically inactive.</s><s xml:id="_J6YGcDz">When assessing the CVD outcome of the overall MHO group, this ratio resulted in an increased, but not statistically significant risk (HR 1.280, p&gt; 0.05).</s><s xml:id="_ZEBrhAV">Therefore, PA can provide a convincing explanation for the discrepant results of previous longitudinal studies about the risk of developing CVD in MHO <ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref>.</s><s xml:id="_6rGuJQA">Taken together, these findings demonstrate that the degree of PA should be considered alongside other determining factors such as obesity and metabolic comorbidity when predicting cardiovascular risk.</s></p><p xml:id="_zYjjSUE"><s xml:id="_BkP2HyP">The main strength of this study is that this was a long-term population-based cohort study (10-year follow up) from a single ethnic group.</s><s xml:id="_GENE49t">This study also has several limitations.</s><s xml:id="_gYZhTpv">First, we were unable to analyze fat distribution or use other demographic indexes associated with obesity such as waist circumference.</s><s xml:id="_yGCAYNr">Therefore, we did not account for all of the important factors associated with CVD risk.</s><s xml:id="_WvXZRmg">Second, since we could not assess mortality data, we may have missed fatal CVD events.</s></p><p xml:id="_2kV3EbV"><s xml:id="_8nkg4YW">In conclusion, we analyzed the CVD outcomes according to obesity and metabolic health status in a Korean population.</s><s xml:id="_dn8u9fP">Physically inactive MHO participants had significantly increased risk of CVD compared to physically active MHNO participants, whereas physically active MHO participants did not.</s><s xml:id="_wjmCG6B">Further studies are required to re-define MHO in view of PA status in order to better characterize 'real' metabolically healthy obesity.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 1 .</head><label>1</label><figDesc><div><p xml:id="_A26m4cJ"><s xml:id="_usFD3tR">Fig 1. Kaplan-Meier curves of CVD events according to metabolic health and obesity status.</s><s xml:id="_fvgzt6n">During ten-year follow-up periods, the metabolically healthy group shows better event-free survival than the metabolic unhealthy group regardless of obesity.</s><s xml:id="_dTum3UH">https://doi.org/10.1371/journal.pone.0185127.g001</s></p></div></figDesc><graphic coords="6,200.01,78.01,287.94,225.41" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><figDesc><div><p xml:id="_MQ6tPkt"><s xml:id="_t7K3mEt">individuals.</s><s xml:id="_EQdfc83">J Am Coll Cardiol 2011; 58:1343-50.</s><s xml:id="_DchbWJ4">https://doi.org/10.1016/j.jacc.2011.04.047</s><s xml:id="_UzdgUUU">PMID:</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_bS5qN68"><s xml:id="_c4GJgMK">PLOS ONE | https://doi.org/10.1371/journal.pone.0185127September</s><s xml:id="_9TAS35h">26, 2017</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_9FzAbtK">Acknowledgments</head><p xml:id="_YBCEQE7"><s xml:id="_JxpGjD8">Data in this study were from the <rs type="institution">Korean Genome and Epidemiology Study (KoGES</rs>; 4851-302).</s><s xml:id="_hE3KeCz"><rs type="funder">National Research Institute of Health, Centers for Disease Control and Prevention, Ministry for Health and Welfare, Republic of Korea</rs>.</s><s xml:id="_CBYrQCE">This research was supported by the grant (C.</s></p></div>
			</div>
			<div type="funding">
<div xml:id="_BFxtpeC"><p xml:id="_VRCeRvG"><s xml:id="_R3pFQKN">This research was supported by the grant (C.M.O., <rs type="grantNumber">2016S-1</rs>) from the <rs type="funder">Korean Diabetes Association, Basic Science Research Program</rs> through the <rs type="funder">National Research Foundation of Korea (NRF)</rs> funded by the <rs type="funder">Ministry of Education</rs> (<rs type="grantNumber">2016R1A6A3A04010466</rs> to C.M.O).</s><s xml:id="_Xr6jK4d">The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_BJFzMaN">
					<idno type="grant-number">2016S-1</idno>
				</org>
				<org type="funding" xml:id="_HYVWxkU">
					<idno type="grant-number">2016R1A6A3A04010466</idno>
				</org>
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_VdZ33Tf"><p xml:id="_Pu5amUU"><s xml:id="_HvFBcPz">All relevant data are within the paper and its Supporting Information files.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_sBcmag4">Supporting information</head><p xml:id="_S52CjCw"><s xml:id="_fDmGHmb">S1 Table .</s><s xml:id="_NFzHwpS">Age and sex adjusted hazard ratios for CVD events according to obesity, metabolic health status and physical activity based on the WHO definition.</s><s xml:id="_fRg4wxt">Abbreviations: MHNO, metabolically healthy nonobese; MHO, metabolically healthy obese; MUNO, metabolically unhealthy nonobese; and MUO, metabolically unhealthy obese; PA, physical activity; HR, hazard ratios; CI, confidential interval.</s><s xml:id="_P3EuPwC">(PDF)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8AF5eNC">Author Contributions</head><p xml:id="_KejXuCF"><s xml:id="_K4U6tJs">Conceptualization: Shinje Moon, Chang-Myung Oh, Moon-Ki Choi, Yoo-Kyung Park, Jae Myung Yu, Hyung Joon Yoo.</s></p><p xml:id="_Vps898w"><s xml:id="_mJX3KHu">Data curation: Shinje Moon, Chang-Myung Oh, Yoo-Kyung Park, Sukyung Chun, Minkyung Choi.</s></p><p xml:id="_3qB53X4"><s xml:id="_uNhZj3c">Formal analysis: Shinje Moon, Chang-Myung Oh, Yoo-Kyung Park, Sukyung Chun, Minkyung Choi.</s></p><p xml:id="_s3pCnC4"><s xml:id="_CanuKEq">Funding acquisition: Chang-Myung Oh.</s></p><p xml:id="_gUufQpN"><s xml:id="_xg74Hxu">Investigation: Shinje Moon, Chang-Myung Oh, Hyung Joon Yoo.</s></p><p xml:id="_RmMFqyR"><s xml:id="_HxwCVtv">Methodology: Shinje Moon, Chang-Myung Oh, Moon-Ki Choi, Sukyung Chun, Jae Myung Yu, Hyung Joon Yoo.</s></p><p xml:id="_TM3qQ49"><s xml:id="_3AVcCZj">Project administration: Chang-Myung Oh, Jae Myung Yu, Hyung Joon Yoo.</s></p><p xml:id="_RdZ3DKq"><s xml:id="_FqrcHhA">Software: Shinje Moon, Yoo-Kyung Park, Sukyung Chun.</s></p><p xml:id="_Ryun48S"><s xml:id="_e2zdW6K">Supervision: Moon-Ki Choi, Jae Myung Yu.</s></p><p xml:id="_FdjA5am"><s xml:id="_vkAAgTk">Writing -original draft: Shinje Moon, Chang-Myung Oh.</s></p><p xml:id="_ZQ93Vnz"><s xml:id="_3NhCNz3">Writing -review &amp; editing: Jae Myung Yu, Hyung Joon Yoo.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_atN2nwT">S-1) from the Korean Diabetes Association, Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_cuj6jJN">R1A6A3A</title>
		<editor>
			<persName><forename type="first">C</forename><forename type="middle">M</forename></persName>
		</editor>
		<imprint>
			<date type="published" when="2016">2016. 2016</date>
			<biblScope unit="page">4010466</biblScope>
		</imprint>
	</monogr>
	<note type="raw_reference">M.O., 2016S-1) from the Korean Diabetes Association, Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Educa- tion (2016R1A6A3A04010466 to C.M.O). References</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main" xml:id="_uJMP7d5">World health statistics</title>
		<idno type="DOI">10.26719/2015.21.6.379</idno>
		<imprint>
			<date type="published" when="2012">2012. 2012</date>
			<publisher>World Health Organization</publisher>
			<pubPlace>Geneva</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization. World health statistics 2012. World Health Organization: Geneva 2012.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<idno type="DOI">10.7570/jomes21056</idno>
		<ptr target="http://www.kosso.or.kr/file/factsheet_1006new6_web.pdf" />
		<title level="m" xml:id="_ZzD7bBC">Korean Society for the Study of Obesity (KSSO): 2016 obesity fact sheet</title>
		<imprint/>
	</monogr>
	<note type="raw_reference">Korean Society for the Study of Obesity (KSSO): 2016 obesity fact sheet. Available from: http://www. kosso.or.kr/file/factsheet_1006new6_web.pdf.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title level="m" type="main" xml:id="_kYAsZNp">Obesity and mortality: a review of the epidemiologic data. The American journal of clinical nutrition</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Solomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Manson</surname></persName>
		</author>
		<idno type="DOI">10.1093/ajcn/66.4.1044s</idno>
		<idno type="PMID">9322585</idno>
		<imprint>
			<date type="published" when="1997">1997</date>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="1044S" to="1050S" />
		</imprint>
	</monogr>
	<note type="raw_reference">Solomon CG, Manson J. Obesity and mortality: a review of the epidemiologic data. The American jour- nal of clinical nutrition. 1997; 66:1044S-50S. PMID: 9322585</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_pZZEjYA">Metabolic and cardiovascular implications of a metabolically healthy obesity phenotype</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Seo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E-J</forename><surname>Rhee</surname></persName>
		</author>
		<idno type="DOI">10.3803/enm.2014.29.4.427</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Mss8K6C">Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="427" to="434" />
			<date type="published" when="2014">2014</date>
			<pubPlace>Seoul</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Seo MH, Rhee E-J. Metabolic and cardiovascular implications of a metabolically healthy obesity pheno- type. Endocrinol Metab (Seoul) 2014; 29: 427-434.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_NTWyJhS">Metabolically healthy obesity: different prevalences using different criteria</title>
		<author>
			<persName><forename type="first">S</forename><surname>Velho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Paccaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Waeber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Vollenweider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Marques-</forename><surname>Vidal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<idno type="DOI">10.1038/ejcn.2010.114</idno>
		<idno type="PMID">20628408</idno>
		<ptr target="https://doi.org/10.1038/ejcn.2010.114" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_KHkF3sv">Eur J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="1043" to="1051" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. Metabolically healthy obesity: differ- ent prevalences using different criteria. Eur J Clin Nutr 2010; 64:1043-51. https://doi.org/10.1038/ejcn. 2010.114 PMID: 20628408</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_zuumxYz">The distinction of metabolically &apos;healthy&apos;from &apos;unhealthy&apos;obese individuals</title>
		<author>
			<persName><forename type="first">M</forename><surname>Blu Â¨her</surname></persName>
		</author>
		<idno type="DOI">10.1097/MOL.0b013e3283346ccc</idno>
		<ptr target="https://doi.org/10.1097/MOL.0b013e3283346cccPMID:19915462" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_mGcAFNS">Curr Opin Lipidol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="38" to="43" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Blu Â¨her M. The distinction of metabolically &apos;healthy&apos;from &apos;unhealthy&apos;obese individuals. Curr Opin Lipidol 2010; 21:38-43. https://doi.org/10.1097/MOL.0b013e3283346ccc PMID: 19915462</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_3wdTWhh">Obesity: to be obese-does it matter if you are metabolically healthy?</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Karelis</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrendo.2011.181</idno>
		<idno type="PMID">22009160</idno>
		<ptr target="https://doi.org/10.1038/nrendo.2011.181" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_KApVYpW">Nat Rev Endocrinol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="699" to="700" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Karelis AD. Obesity: to be obese-does it matter if you are metabolically healthy? Nat Rev Endocrinol 2011; 7:699-700. https://doi.org/10.1038/nrendo.2011.181 PMID: 22009160</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_YMWqf6M">Comparison of metabolic characteristics of metabolically healthy but obese (MHO) middle-aged men according to different criteria</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Yoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Y</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y-S</forename><surname>Cheong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Bae</surname></persName>
		</author>
		<idno type="DOI">10.4082/kjfm.2013.34.1.19</idno>
		<idno type="PMID">23372902</idno>
		<ptr target="https://doi.org/10.4082/kjfm.2013.34.1.19" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_puGVjzC">Korean J Fam Med</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="19" to="26" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yoo HK, Choi EY, Park EW, Cheong Y-S, Bae RA. Comparison of metabolic characteristics of metaboli- cally healthy but obese (MHO) middle-aged men according to different criteria. Korean J Fam Med 2013; 34:19-26. https://doi.org/10.4082/kjfm.2013.34.1.19 PMID: 23372902</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_rgGYB4d">The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used</title>
		<author>
			<persName><forename type="first">Rey-Lo</forename><surname>Â´pez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rezende</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pastor-Valero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Tess</forename><forename type="middle">B</forename></persName>
		</author>
		<idno type="DOI">10.1111/obr.12198</idno>
		<ptr target="https://doi.org/10.1111/obr.12198PMID:25040597" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_8mZQZSU">Obes Rev</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="781" to="790" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rey-Lo Â´pez J, Rezende L, Pastor-Valero M, Tess B. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev 2014; 15:781-90. https://doi. org/10.1111/obr.12198 PMID: 25040597</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_ngw2r5Z">Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hamer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Stamatakis</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2011-3475</idno>
		<ptr target="https://doi.org/10.1210/jc.2011-3475PMID:22508708" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_7jAWXh9">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="2482" to="2488" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012; 97:2482-8. https://doi.org/10.1210/jc.2011-3475 PMID: 22508708</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_YJJsNhB">Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese 12</title>
		<author>
			<persName><forename type="first">C</forename><surname>Voulgari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tentolouris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dilaveris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tousoulis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Katsilambros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C ;</forename><surname>Stefanadis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Morkedal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Vatten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Romundstad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Laugsand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Janszky</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2013.11.035</idno>
		<idno type="PMID">24345592</idno>
		<ptr target="https://doi.org/10.1016/j.jacc.2013.11.035" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_XMBkZdz">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1071" to="1078" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals</note>
	<note type="raw_reference">Voulgari C, Tentolouris N, Dilaveris P, Tousoulis D, Katsilambros N, Stefanadis C. Increased heart fail- ure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese 12. Morkedal B, Vatten LJ, Romundstad PR, Laugsand LE, Janszky I. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals. J Am Coll Cardiol 2014; 63:1071-8. https://doi.org/10.1016/j.jacc.2013.11.035 PMID: 24345592</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_Hy5CYFB">Incident cardiovascular disease events in metabolically benign obese individuals</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Ogorodnikova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Mcginn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Muntner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Wildman</surname></persName>
		</author>
		<idno type="DOI">10.1038/oby.2011.243</idno>
		<idno type="PMID">21799477</idno>
		<ptr target="https://doi.org/10.1038/oby.2011.243" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_PrwWphh">Obesity</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="651" to="659" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U, Wildman RP. Incident cardiovascular dis- ease events in metabolically benign obese individuals. Obesity. 2012; 20:651-9. https://doi.org/10. 1038/oby.2011.243 PMID: 21799477</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_9QxbnhX">Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zinman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Retnakaran</surname></persName>
		</author>
		<idno type="DOI">10.7326/0003-4819-159-11-201312030-00008</idno>
		<idno type="PMID">24297192</idno>
		<ptr target="https://doi.org/10.7326/0003-4819-159-11-201312030-00008" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_PVKAnKj">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="758" to="769" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign condi- tions? A systematic review and meta-analysis. Ann Intern Med 2013; 159:758-69. https://doi.org/10. 7326/0003-4819-159-11-201312030-00008 PMID: 24297192</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_8Hju6Vd">Physical activity in obesity and metabolic syndrome</title>
		<author>
			<persName><forename type="first">B</forename><surname>Strasser</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1749-6632.2012.06785.x</idno>
		<idno type="PMID">23167451</idno>
		<ptr target="https://doi.org/10.1111/j.1749-6632.2012.06785.x" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ch3eRTX">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">1281</biblScope>
			<biblScope unit="page" from="141" to="159" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Strasser B. Physical activity in obesity and metabolic syndrome. Ann N Y Acad Sci 2013; 1281:141-59. https://doi.org/10.1111/j.1749-6632.2012.06785.x PMID: 23167451</note>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<idno type="DOI">10.26719/2015.21.6.379</idno>
		<title level="m" xml:id="_zR7nKnZ">Global recommendations on physical activity for health</title>
		<meeting><address><addrLine>Geneva</addrLine></address></meeting>
		<imprint>
			<publisher>World Health Organization</publisher>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">World Health Organization. Global recommendations on physical activity for health. World Health Orga- nization: Geneva 2010.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_sQu4kse">Physical activity in US adults: compliance with the physical activity guidelines for Americans</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Tucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Welk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Beyler</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amepre.2010.12.016</idno>
		<idno type="PMID">21406280</idno>
		<ptr target="https://doi.org/10.1016/j.amepre.2010.12.016" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_JeksbeJ">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="454" to="461" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tucker JM, Welk GJ, Beyler NK. Physical activity in US adults: compliance with the physical activity guidelines for Americans. Am J Prev Med. 2011; 40: 454-461. https://doi.org/10.1016/j.amepre.2010. 12.016 PMID: 21406280</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_dAnNtfR">Physical activity and cardiovascular health</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Shiroma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I-M</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.109.914721</idno>
		<idno type="PMID">20713909</idno>
		<ptr target="https://doi.org/10.1161/CIRCULATIONAHA.109.914721" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_9rE99tK">Circulation</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="743" to="752" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shiroma EJ, Lee I-M. Physical activity and cardiovascular health. Circulation. 2010; 122:743-52. https://doi.org/10.1161/CIRCULATIONAHA.109.914721 PMID: 20713909</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_mb7xrqZ">The effect of regular exercise on insulin sensitivity in type 2 diabetes mellitus: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Way</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Hackett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<idno type="DOI">10.4093/dmj.2016.40.4.253</idno>
		<idno type="PMID">27535644</idno>
		<ptr target="https://doi.org/10.4093/dmj.2016.40.4.253" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_BTBmV2J">Diabetes Metab J</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="253" to="271" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Way KL, Hackett DA, Baker MK, Johnson NA. The effect of regular exercise on insulin sensitivity in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab J 2016; 40:253-71. https:// doi.org/10.4093/dmj.2016.40.4.253 PMID: 27535644</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_6NeXtDQ">Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Cho</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc10-0644</idno>
		<ptr target="https://doi.org/10.2337/dc10-0644PMID:21335372" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_2yhcWFd">Diabetes care</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="944" to="949" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Choi SH, Kim TH, Lim S, Park KS, Jang HC, Cho NH. Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction. Diabetes care. 2011; 34:944-9. https://doi.org/10.2337/ dc10-0644 PMID: 21335372</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_VfKTRbD">Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan</title>
		<author>
			<persName><forename type="first">W-Y</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L-T</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H-H</forename><surname>Hsia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I-L</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.ijo.0802040</idno>
		<ptr target="https://doi.org/10.1038/sj.ijo.0802040PMID:12187401" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_Jz6AEMh">Int J Obes Relat Metab Disord</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1232" to="1238" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lin W-Y, Lee L-T, Chen C-Y, Lo H, Hsia H-H, Liu I-L, et al. Optimal cut-off values for obesity: using sim- ple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Dis- ord 2002; 26:1232-8. https://doi.org/10.1038/sj.ijo.0802040 PMID: 12187401</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_uV6KYSr">Accuracy of current body mass index obesity classification for white, black and Hispanic reproductive-age women</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Berenson</surname></persName>
		</author>
		<idno type="DOI">10.1097/aog.0b013e3181da9423</idno>
		<idno type="PMID">20410772</idno>
		<ptr target="https://doi.org/10.1097/AOG.0b013e3181da9423" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_avBEC7u">Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page">982</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rahman M, Berenson AB. Accuracy of current body mass index obesity classification for white, black and Hispanic reproductive-age women. Obstet Gynecol 2010; 115:982. https://doi.org/10.1097/AOG. 0b013e3181da9423 PMID: 20410772</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_8RUFTYg">Brown and beige fat: development, function and therapeutic potential</title>
		<author>
			<persName><forename type="first">M</forename><surname>Harms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Seale</surname></persName>
		</author>
		<idno type="DOI">10.1038/nm.3361</idno>
		<ptr target="https://doi.org/10.1038/nm.3361PMID:24100998" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_fRHCDQ4">Nat Med</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1252" to="1263" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med 2013; 19:1252-63. https://doi.org/10.1038/nm.3361 PMID: 24100998</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_HdEPdvu">Metabolic effects of visceral fat accumulation in type 2 diabetes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gastaldelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Miyazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pettiti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Matsuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mahankali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Santini</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2002-020696</idno>
		<ptr target="https://doi.org/10.1210/jc.2002-020696PMID:12414878" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_xRyUxHQ">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="5098" to="5103" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gastaldelli A, Miyazaki Y, Pettiti M, Matsuda M, Mahankali S, Santini E, et al. Metabolic effects of vis- ceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 2002; 87:5098-103. https://doi.org/ 10.1210/jc.2002-020696 PMID: 12414878</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_NQJP5KM">Visceral adiposity, insulin resistance and cancer risk</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Donohoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Doyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Reynolds</surname></persName>
		</author>
		<idno type="DOI">10.1186/1758-5996-3-12</idno>
		<ptr target="https://doi.org/10.1186/1758-5996-3-12PMID:21696633" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_3hNCzt3">Diabetol Metab Syndr</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">12</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Donohoe CL, Doyle SL, Reynolds JV. Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr 2011; 3:12. https://doi.org/10.1186/1758-5996-3-12 PMID: 21696633</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_NutVq3g">Maintenance of Subcutaneous Fat Homeostasis Improves Systemic Metabolic Dysfunction in Obesity</title>
		<author>
			<persName><forename type="first">I</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Minamino</surname></persName>
		</author>
		<idno type="DOI">10.2337/dbi15-0013</idno>
		<ptr target="https://doi.org/10.2337/dbi15-0013PMID:26604172" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_r9MWnhp">Diabetes</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="3984" to="3986" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shimizu I, Yoshida Y, Minamino T. Maintenance of Subcutaneous Fat Homeostasis Improves Systemic Metabolic Dysfunction in Obesity. Diabetes. 2015; 64:3984-6. https://doi.org/10.2337/dbi15-0013 PMID: 26604172</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_qTtjnyE">Beneficial effects of subcutaneous fat transplantation on metabolism</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gesta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Kahn</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cmet.2008.04.004</idno>
		<idno type="PMID">18460332</idno>
		<ptr target="https://doi.org/10.1016/j.cmet.2008.04.004" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZNJUP6g">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="410" to="420" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008; 7:410-20. https://doi.org/10.1016/j.cmet.2008.04.004 PMID: 18460332</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_AxtU4Tw">Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Yousafzai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Darwish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Al-Hamaq</forename><surname>Ao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Nasralla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Abdul</forename><forename type="middle">-</forename><surname>Ghani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.1155/2013/269038</idno>
		<ptr target="https://doi.org/10.1155/2013/269038PMID:24000310" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_9BHGghP">J Obes</title>
		<imprint>
			<date type="published" when="2013">2013. 2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bener A, Yousafzai MT, Darwish S, Al-Hamaq AO, Nasralla EA, Abdul-Ghani M. Obesity index that bet- ter predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio. J Obes 2013; 2013. https://doi.org/10.1155/2013/269038 PMID: 24000310</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_w7AqHgW">Waist circumference and not body mass index explains obesityrelated health risk</title>
		<author>
			<persName><forename type="first">I</forename><surname>Janssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Katzmarzyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ross</surname></persName>
		</author>
		<idno type="DOI">10.1093/ajcn/79.3.379</idno>
		<idno type="PMID">14985210</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Pj3nfdX">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="379" to="384" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity- related health risk. Am J Clin Nutr 2004; 79:379-84. PMID: 14985210</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_Zdvqr94">Measuring body composition</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wells</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fewtrell</surname></persName>
		</author>
		<idno type="DOI">10.1136/adc.2005.085522</idno>
		<idno type="PMID">16790722</idno>
		<ptr target="https://doi.org/10.1136/adc.2005.085522" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ArD7fQM">Arch Dis Child</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="612" to="617" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wells J, Fewtrell M. Measuring body composition. Arch Dis Child 2006; 91:612-7. https://doi.org/10. 1136/adc.2005.085522 PMID: 16790722</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_ZfxcDus">Brown fat at PET/CT: correlation with patient characteristics</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Cronin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Prakash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Daniels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Boland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Kalra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Halpern</surname></persName>
		</author>
		<idno type="DOI">10.1148/radiol.12100683</idno>
		<idno type="PMID">22623697</idno>
		<ptr target="https://doi.org/10.1148/radiol.12100683" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ymNAvJC">Radiology</title>
		<imprint>
			<biblScope unit="volume">263</biblScope>
			<biblScope unit="page" from="836" to="842" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cronin CG, Prakash P, Daniels GH, Boland GW, Kalra MK, Halpern EF, et al. Brown fat at PET/CT: cor- relation with patient characteristics. Radiology. 2012; 263:836-42. https://doi.org/10.1148/radiol. 12100683 PMID: 22623697</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_ghJu2JA">Physical activity and risk of cardiovascular disease-a meta-analysis of prospective cohort studies</title>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Siegrist</surname></persName>
		</author>
		<idno type="DOI">10.3390/ijerph9020391</idno>
		<ptr target="https://doi.org/10.3390/ijerph9020391PMID:22470299" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_45CcuJ4">Int J Environ Res Public Health</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="391" to="407" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Li J, Siegrist J. Physical activity and risk of cardiovascular disease-a meta-analysis of prospective cohort studies. Int J Environ Res Public Health 2012; 9:391-407. https://doi.org/10.3390/ijerph9020391 PMID: 22470299</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_KYEy268">Physical activity is associated with percent body fat and body composition but not body mass index in white and black college students</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zanovec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Lakkakula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Turri</surname></persName>
		</author>
		<idno type="DOI">10.70252/mdok6464</idno>
		<idno type="PMID">27182315</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BUCqT8T">Int J Exerc Sci</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">175</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zanovec M, Lakkakula AP, Johnson LG, Turri G. Physical activity is associated with percent body fat and body composition but not body mass index in white and black college students. Int J Exerc Sci 2009; 2:175. PMID: 27182315</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_9hXaYhe">Association between habitual physical activity and brown adipose tissue activity in individuals undergoing PET-CT scan</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Dinas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nikaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Z</forename><surname>Jamurtas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Prassopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Efthymiadou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Koutedakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WvEPHqa">Clin Endocrinol (Oxf)</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="147" to="154" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dinas PC, Nikaki A, Jamurtas AZ, Prassopoulos V, Efthymiadou R, Koutedakis Y, et al. Association between habitual physical activity and brown adipose tissue activity in individuals undergoing PET-CT scan. Clin Endocrinol (Oxf) 2015; 82:147-54.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_eWGVanF">Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ingelsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sundstro Â¨m</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lind</surname></persName>
		</author>
		<idno type="DOI">10.1161/CIRCULATIONAHA.109.887521</idno>
		<idno type="PMID">20038741</idno>
		<ptr target="https://doi.org/10.1161/CIRCULATIONAHA.109.887521" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZJc95Z4">Circulation</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="230" to="236" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">A Â¨rnlo Â¨v J, Ingelsson E, Sundstro Â¨m J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010; 121:230-6. https:// doi.org/10.1161/CIRCULATIONAHA.109.887521 PMID: 20038741</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_6vaV8mv">Metabolically healthy obesity and risk of mortality</title>
		<author>
			<persName><forename type="first">G-M</forename><surname>Hinnouho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Czernichow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dugravot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Batty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kivimaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Singh-Manoux</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc12-1654</idno>
		<ptr target="https://doi.org/10.2337/dc12-1654PMID:23637352" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_rpQp2hr">Diabetes care</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="2294" to="2300" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hinnouho G-M, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A. Metabolically healthy obesity and risk of mortality. Diabetes care. 2013; 36:2294-300. https://doi.org/10.2337/dc12- 1654 PMID: 23637352</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_2GdPSAs">The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Ortega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D-C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Katzmarzyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Ruiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Sui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Church</surname></persName>
		</author>
		<idno type="DOI">10.1093/eurheartj/ehs174</idno>
		<ptr target="https://doi.org/10.1093/eurheartj/ehs174PMID:22947612" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_rqBNZdu">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="389" to="397" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ortega FB, Lee D-c, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013; 34:389- 97. https://doi.org/10.1093/eurheartj/ehs174 PMID: 22947612</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_xrBbAW3">Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-TrÃ¸ndelag Health Study), Norway</title>
		<author>
			<persName><forename type="first">B</forename><surname>MÃ¸rkedal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Vatten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Romundstad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Laugsand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Janszky</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2013.11.035</idno>
		<idno type="PMID">24345592</idno>
		<ptr target="https://doi.org/10.1016/j.jacc.2013.11.035" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_dr8kCKQ">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="1071" to="1078" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">MÃ¸rkedal B, Vatten LJ, Romundstad PR, Laugsand LE, Janszky I. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-TrÃ¸ndelag Health Study), Norway. J Am Coll Cardiol 2014; 63:1071-8. https://doi.org/10.1016/j.jacc.2013.11.035 PMID: 24345592</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
